INTRODUCTION
============

Coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) ([@B01],[@B02]). The first case of this disease was reported in Wuhan, Hubei province, China, in December 2019 ([@B03]). Since March 2020, COVID-19 has spread worldwide and has become a public health emergency and a pandemic of international concern ([@B04]).

COVID-19 is extremely contagious and, in certain cases, may rapidly progress to severe acute respiratory syndrome. An unexpectedly high rate of SARS-CoV-2 infection has been observed worldwide. An age gradient in the risk of death was identified, and patients older than 60 years were reported to have a higher mortality rate ([@B05],[@B06]), with a case fatality rate close to 8-10% ([@B05],[@B06]). Moreover, the presence of comorbidities results in increased mortality, with multiorgan dysfunction ([@B01],[@B02]).

Data on COVID-19 in solid organ transplant (SOT), liver transplant (LT), and kidney transplant (KT) patients are scarce ([@B07]). Mazzafero et al. ([@B08]) reported a novel experience with several COVID-19 cases at an Italian transplant center in Lombardy ([@B08]). Another case series from Italy showed that children who had received LTs were not at a higher risk for severe SARS-CoV-2 infection despite being immunosuppressed ([@B09]).

Transplant societies and guidelines were initially established to decrease the risk of infection and protect health care professionals. Recipients and donors may be at risk of being carriers of SARS-CoV-2 or contracting active COVID-19 through contact with patients who have COVID-19 or through exposure to SARS-CoV-2 ([@B10]).

Insufficient data on infected SOT recipients are available, particularly data regarding the management of immunosuppressants and fatality rates. This review aimed to collate the available data that address the management of COVID-19 infection in abdominal SOT patients.

METHODS
=======

Study identification
--------------------

A systematic review of the literature on COVID-19 and transplantation was carried out. The MEDLINE and PubMed databases (<http://www.ncbi.nlm.nih.gov/pubmed>) were electronically searched and updated until April 20, 2020. The MeSH terms used were "COVID-19" (entire related MeSH terms: 2019 novel coronavirus, SARS-CoV-2 infection, 2019-nCoV infection) AND "transplant." The electronic bibliographic database included MEDLINE-PubMed, EMBASE, Cochrane Library, and Web of Science.

The terms and MeSH terms for the PubMed database search were developed with the PICO structure: patient, intervention, comparison or control, and outcome (PICO). The terms for each group were combined with the "OR" operator. The results of the search terms forming the "P" (Patients) group were combined with those of search terms forming the "I" (Intervention) group, with "AND," and for exclusion terms, with "NOT."

[Participants/population]{.ul}: Adults and children who were abdominal organ recipients and were diagnosed as having COVID-19. [Intervention(s), exposure(s)]{.ul}: Adults and children who were abdominal SOT recipients and tested positive for COVID-19 that progressed to severe acute respiratory syndrome. [Comparator(s)/control]{.ul}: The control group was selected from the group of patients who were not exposed to SARS-CoV-2. We evaluated other groups of LT and KT patients and various epidemiologic groups such as those matched for age, sex, and comorbidities. [Context Main outcome(s)]{.ul}: Survival after SARS-CoV-2 infection and outcomes related to medical management, as a potential therapy to this infection in this population; establishing guidelines and programs to better treat this population.

This systematic review was registered in the international database of prospectively registered systematic reviews (PROSPERO, registration number=CRD42020181299). The review protocol can be accessed online via the PROSPERO website (<https://www.crd.york.ac.uk/prospero/>). The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) checklist was adhered to when preparing this manuscript ([@B11],[@B12],[@B13]). The review methodology followed the recommendations published by PRISMA ([@B11],[@B12],[@B13]).

Study selection
---------------

### Inclusion and exclusion criteria

Selection criteria were used within the research question of the PICO structure. All studies evaluated were written in English.

Case reports, letters to the editor, clinical randomized controlled trials, non-randomized controlled trials, reviews, consensus articles, and protocol studies were included. Studies on organs other than the liver and kidneys, those on tissues transplants, those on a novel therapy for COVID-19, those on the impact of COVID-19 on the transplant system, those on vaccine research, those involving patients on hemodialysis, those on the clinical manifestation of COVID-19, epidemiologic studies, those on elective or non-transplant surgical procedures, and those on immunosuppression protocols that were unrelated to abdominal SOT and COVID-19 were excluded.

### Study data extraction

Data extraction was carried out independently by two researchers, using the text, tables, and figures of the original published articles. The quality of the studies selected and the selection methods were evaluated by two independent researchers (LSN and LYZ). In the case of a disagreement, the researchers held a consensus meeting to reach a final decision.

### Statistical analysis

Quantitative and qualitative variables were presented as number and percentage, median and range, or mean and standard deviation. The COVID-19 prevalence and fatality rates of patients who were older than 60 years were calculated and compared. A Mann-Whitney *U* test was used to compare independent samples, and *p*\<0.05 was considered significant. All tests were performed using IBM SPSS 25 software, with α=0.05 and a 95% confidence interval.

The data were generated using Review Manager Version 5.3 software provided by the Cochrane Collaboration (RevMan; The Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen, Denmark).

RESULTS
=======

Study selection
---------------

The literature search revealed 113 articles, of which 24 articles were selected and analyzed in this review. [Figure 1](#f01){ref-type="fig"} depicts the flow diagram of the systematic literature search, according to the PRISMA statement, and the selection criteria for the articles.

We did not find well-designed randomized control trials, cohorts, or prospective or retrospective studies. Most articles were case series, letters to the editor, and editorials.

Data extraction and synthesis were performed specifically using articles on SOT with COVID-19 infection, that is, 24 articles. There were 11 articles regarding Liver transplantation ([Table 1](#t01){ref-type="table"}), 14 articles on Kidney transplantation ([Table 2](#t02){ref-type="table"}), and one article on SOT as presented with liver and KT.

Solid organ transplant patients
-------------------------------

Twenty-four articles on SOT patients were selected. Thirty-nine cases were related to SOT and COVID-19 infection. The median interval since transplantation to COVID-19 infection was 4 years (range, 0.01 - 30.10). The overall fatality rate in solid organ transplant patients was 25.64% (10/39), and the fatality rate was 52.94% in patients older than 60 years (*p*=0.001; [Table 3](#t03){ref-type="table"}).

Liver transplant patients
-------------------------

From the 11 articles included in the analysis of LT patients infected by SARS-CoV-2, seven were case reports/correspondences ([@B08],[@B09],), 3 were consensuses ([@B19]-[@B21]), and one article was a case series on overall SOT ([@B07]). The LT group included a total of 16 cases, with a median interval since transplantation of 5.95 years (range, 0.01-26.5). These cases involved transplants in pediatric and adult patients, with no reported deaths in children. Tacrolimus administration was discontinued in two cases, with satisfactory evolution of these patients; however, therapy with methylprednisolone was maintained ([Table 1](#t01){ref-type="table"}). The LT case fatality rate was 37.5% (6/16). Six patients evolved to death, more than 3 years after LT, with the youngest being 59 years of age ([Table 1](#t01){ref-type="table"} and [Table 3](#t03){ref-type="table"}).

Kidney transplant patients
--------------------------

Fourteen articles were included in the analysis of KT patients with COVID-19. Among these, six were case reports/case series ([@B22]-[@B27]), five were correspondences ([@B10],), one was a guideline ([@B32]), one an editorial ([@B33]), and one was a case series on SOT ([@B07]). Twenty-three KT cases were described. The median interval since transplantation was 4 years (range, 0.25-30.1). The fatality rate among KT patients was 17.4% (4/23), and the youngest patient who died was 71 years. Immunosuppressive therapy was reduced or suspended in 13 cases, with good clinical evolution in eight patients ([Table 2](#t02){ref-type="table"} and [3](#t03){ref-type="table"}).

DISCUSSION
==========

The transplant society's recommendations and guidelines during the COVID-19 pandemic, with insufficient evidence, consider LT and KT as safe procedures. The transplant team should discuss the real risks and benefits of the procedure and of immunosuppression therapy. On the basis of the scarce data on SARS-CoV-2 infection, it is suggested that therapy for COVID-19 patients be individualized. This review provided data on SOT and COVID-19 infection.

In their study, Mazzafero et al. ([@B08]) reported that three patients with severe COVID-19 among 111 long-term LT survivors (who had undergone transplantation more than 10 years ago) died. The post-transplant course had been uneventful for all three patients, and their immunosuppressive regimen had been tapered gradually, with very low trough concentrations of calcineurin inhibitors (two patients receiving ciclosporin and one receiving tacrolimus) ([@B08]).

D'Antiga et al. ([@B09]) reported a case series from a single center in Italy, wherein children who received LTs were not at increased risk for severe SARS-CoV-2 infection compared with the general population despite being immunosuppressed ([@B09]). Nevertheless, this series was biased as it involved the study of a population of children, which has a lower incidence rate of SARS-CoV-2 infection.

The American Association for the Study of Liver Diseases suggests that immunosuppression should not be reduced or stopped in asymptomatic LT recipients ([@B21]). Immunosuppression, despite its immunomodulatory effect, did not seem to increase the risk of severe COVID-19 disease in transplantation patients. Given that a reactive innate immune response might be responsible for the severe clinical manifestations of SARS-CoV-2 infection, immunosuppression might be protective against COVID-19; however, this needs further clarification.

Unrecognized COVID-19 infection among transplantation recipients largely increases the potential of development of severe immune suppression and postsurgical infection, which may lead to multisystem organ damage or death. A donor with unidentified COVID-19 infection may also spread the virus to multiple recipients. The therapeutic paradox is compelling in such patients: insufficient immunosuppression results in graft loss due to rejection, whereas excessive immunosuppression results in severe infection. Strict screening protocols for organ transplant recipients and donors, aimed at identifying carriers of SARS-CoV-2, must be developed to aid in reducing further transmission ([@B14]). However, the scarce data must be better analyzed with more prolonged follow-up, and evaluations should be carried out in recipients with COVID-19 infection.

Fernandez-Ruiz et al. ([@B07]) reported on 18 SOT recipients with COVID-19. The majority of patients were KT recipients (44.4% \[8/18\]), followed by LT (33.3% \[6/18\]) and heart transplant recipients (22.2% \[4/18\]). The median patient age was 71.0±12.8 years, with a predominance of male patients (77.8% \[14/18\]), and the median interval since transplantation was 9.3 years. The case fatality rate was 27.8% (5/18). Their study suggests that SARS-CoV-2 infection had a severe course in SOT recipients ([@B07]). Moreover, this finding differs from those of other publications, which report similar results in non-transplanted patients with COVID-19 infection. However, the current study, which analyzed overall SOT cases, found that the median interval from transplantation to COVID-19 infection was 4 years, and the case fatality rate was 25.64% (10/39). Therefore, we demonstrated that SOT populations have a higher mortality risk than that in non-transplanted populations.

Moreover, Verity et al. ([@B05]) demonstrated an age gradient in the risk of death in a COVID-19-infected population, which showed that early estimates indicate the fatality ratio ([@B05]). According to their findings, there was an increase in the severity of COVID-19 with age in patients older than 60 years, along with a higher fatality rate ([@B06]). Moreover, in this study, we observed a significant increase in fatality risk among SOT patients older than 60 years.

The main limitations of this study were that only case series and editorials on the topic were found in the literature. To the best of our knowledge, the number of cases with patients who had undergone SOT and were infected with COVID-19 is considerably low. Further, only this review was registered in the PROSPERO database (<https://www.crd.york.ac.uk/prospero/>). However, there are several ongoing clinical trials on COVID-19 (<https://clinicaltrials.gov/ct2/results?cond=COVID-19>). Further data is warranted for more definitive recommendations. The main contributions of this systematic review are the novel description of COVID-19 infection in SOT recipients (LT and KT), especially in terms of the management of the disease and immunosuppression therapy, and the fact that it alerts medical professionals to the higher fatality risk in SOT patients older than 60 years.

CONCLUSION
==========

This study presents a novel description of COVID-19 infection in abdominal SOT recipients. Furthermore, we alert medical professionals to the higher fatality risk in the population of patients older than 60 years.
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###### COVID-19 infection in liver transplant patients.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Article                                                  Patients                                                            Clinical manifestation                                                                                                       Laboratorial exams                                       Treatment                                                                                      Outcome
  -------------------------------------------------------- ------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------- ---------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------
  Zhong et al. (16) and Qin et al. (14) (Case report)      37 years old\                                                       -Fever (38.6°C)\                                                                                                             -WBC 2.46×10^9^/L\                                       -UCI\                                                                                          -After 2 days in UCI, satisfactory evolution\
                                                           Male\                                                               -SpO~2~ 94%\                                                                                                                 -Platelets 74×10^9^/L\                                   -Tacrolimus use was suspended\                                                                 -However, after 14 days of FK suspension, presented with possible graft dysfunction\
                                                           VHB+HCC\                                                            -Weakness\                                                                                                                   -Lymphs 0.48×10^9^/L\                                    -Administrated intravenous methylprednisolone (40 mg; 12/12h)\                                 -Patient underwent MPA pulse therapy with satisfactory evolution
                                                           9 days after LT\                                                    -Abdominal discomfort\                                                                                                       -ALT 240 U/L\                                            -Oseltamivir\                                                                                  
                                                           FK+MPA                                                              -Sleep disorders                                                                                                             -TBIL 38.9 μmol/L\                                       -Cefoperazone\                                                                                 
                                                                                                                                                                                                                                                            -RT-PCR positive for SARS-CoV-2\                         -Sulbactam sodium                                                                              
                                                                                                                                                                                                                                                            -CT scan showed bilateral glass density lesions                                                                                                         

  Huang et al. (17) (Case report)                          59 years old\                                                       Three days of fever (40°C), cough, chills, fatigue, and diarrhea. HR of 112 beats/min, jaundice, splenomegaly, and ascites   -WBC 3.2×10^9^/L,\                                       -UCI\                                                                                          -On the 12^th^ day of hospitalization, patient had positive cultures of *Candida albicans* and *Pseudomonas aeruginosa*\
                                                           Male\                                                                                                                                                                                            -Lymphs 0.7×109/L\                                       -Nebulized α- interferon\                                                                      -Worsening of hepatic and renal function\
                                                           VHB+HCC\                                                                                                                                                                                         -CRP 35.1 mg/L,\                                         -Umifenovir\                                                                                   -Plasma, immunoglobulin, blood transfusion, and hemodialysis were used\
                                                           3 years after LT\                                                                                                                                                                                -TBIL 83.9 μmol/L,\                                      -Lopinavir/ritonavir\                                                                          -On the 33rd hospitalization day, RT-PCR was negative for SARS-CoV-2, but the patient evolved to death on the 47th day
                                                           FK+MMF                                                                                                                                                                                           -ALT 60 U/L\                                             -Piperacillin and tazobactam (empirical)\                                                      
                                                                                                                                                                                                                                                            -GGT 1087 U/L\                                           -Required invasive ventilation (day 4)                                                         
                                                                                                                                                                                                                                                            -RT-PCR positive for SARS-CoV-2\                                                                                                                        
                                                                                                                                                                                                                                                            -CT scan showed bilateral glass density lesions                                                                                                         

  Bin et al. (18) (Case report)                            50 years old\                                                       -Fever (39.6°C) but initially low fever\                                                                                     -WBC 5.9×10^9^/L -CRP 32.1 mg/L\                         -Discontinued FK and received systemic MPA\                                                    -Patient had a satisfactory clinical evolution, with no complications and no liver dysfunction
                                                           Male VHB\                                                           -Progressive dyspnea                                                                                                         -RT-PCR positive for SARS-CoV-2\                         -Cefoperazone (prophylactic)\                                                                  
                                                           3 years after LT\                                                                                                                                                                                -CT scan showed bilateral glass density lesions          -Umifenovir -Lopinavir/ritonavir\                                                              
                                                           FK                                                                                                                                                                                                                                                        -Immunoglobulin\                                                                               
                                                                                                                                                                                                                                                                                                                     -Nebulized α- interferon                                                                       

  Bhoori et al. (8) (Correspondence)                       3 patients, \>65 years old\                                         Hospital admission with community-acquired pneumonia and quickly developed severe respiratory distress syndrome              Positive nasopharyngeal swab test for SARS-CoV-2         -UCI\                                                                                          All three patients evolved to death 3-12 days after the first pneumonia symptoms manifested
                                                           All male\                                                                                                                                                                                                                                                 -Required invasive ventilation                                                                 
                                                           \>10 years of LT\                                                                                                                                                                                                                                                                                                                                        
                                                           Two patients receiving ciclosporin and one FK                                                                                                                                                                                                                                                                                                            

  D'Antiga L (9) (Correspondence)                          3 liver transplant children (From 700 LT)                           None of the three patients had a clinical manifestation                                                                      Positive nasopharyngeal swab test for SARS-CoV-2         None                                                                                           The three transplanted children did not develop any symptoms of COVID-19

  Lagana S. et al. (15) (Case report)                      6 female months children\                                           -Fever\                                                                                                                      -RT-PCR positive for SARS-CoV-2\                         -Hydroxychloroquine                                                                            Patient still hospitalized, but with mild respiratory symptoms
                                                            Biliary atresia\                                                   -Dyspnea (employed CPAP)\                                                                                                    -Liver biopsy: mixed inflammatory infiltrate (lymphs)\                                                                                                  
                                                            LDLT\                                                              -Diarrhea                                                                                                                    -Interlobular bile ducts with lymphocytic cholangitis                                                                                                   
                                                           COVID-19 infection manifestation 2 days after LT                                                                                                                                                                                                                                                                                                         

  Fernández-Ruiz et al. (7) (Case series)                  [Case 1]{.ul}\                                                      -Fever\                                                                                                                      -Unifocal consolidation on chest X-Ray\                  -Hydroxychloroquine\                                                                           -Patient had a satisfactory clinical evolution, with no complications
                                                           -63 years old\                                                      -SpO~2~ 96%\                                                                                                                 -Positive nasopharyngeal swab test for SARS-CoV-2        -Lopinavir/ritonavir\                                                                          
                                                           -Male\                                                              -Dyspnea\                                                                                                                                                                             -Suspension of everolimus and substitution to FK +MMF                                          
                                                           -COVID-19 infection manifestation 7.9 years after LT HBV+HCV+HCC\   -Cough\                                                                                                                                                                                                                                                                              
                                                           -Everolimus                                                         -Diarrhea\                                                                                                                                                                                                                                                                           
                                                                                                                               -Myalgia\                                                                                                                                                                                                                                                                            
                                                                                                                               -Diarrhea                                                                                                                                                                                                                                                                            

  [Case 2]{.ul}\                                           -Fever\                                                             -Multifocal consolidation on chest X-Ray\                                                                                    -Hydroxychloroquine\                                     -Patient had worsening respiratory function and renal failure. Evolved to death after 7 days   
  -72 years old\                                           -SpO~2~ 95%\                                                        -Positive nasopharyngeal swab test for SARS-CoV-2                                                                            -Lopinavir/ritonavir\                                                                                                                                   
  -Male\                                                   -Dyspnea\                                                                                                                                                                                        -Interferon-β\                                                                                                                                          
  -COVID-19 infection manifestation 5.5 years after LT\    -Cough                                                                                                                                                                                           -Substitution of Everolimus+MMF to FK                                                                                                                   
  Cryptogenic cirrhosis Everolimus+MMF                                                                                                                                                                                                                                                                                                                                                                              

  [Case 3]{.ul}\                                           -SpO~2~ 96%\                                                        -Bilateral consolidation on chest X-Ray\                                                                                     -Hydroxychloroquine\                                     -Patient had a satisfactory clinical evolution, with no complications                          
  -79 years old\                                           -Dyspnea\                                                           -Positive nasopharyngeal swab test for SARS-CoV-2                                                                            -Interferon-β\                                                                                                                                          
  -Female\                                                 -Cough\                                                                                                                                                                                          -Immunosuppressive drugs maintained                                                                                                                     
  -COVID-19 infection manifestation 15.3 years after LT\   -Malaise\                                                                                                                                                                                                                                                                                                                                                
  -HCV+HCC\                                                -Diarrhea                                                                                                                                                                                                                                                                                                                                                
  -Prednisone+AZA+ Everolimus                                                                                                                                                                                                                                                                                                                                                                                       

  [Case 4]{.ul}\                                           -Fever\                                                             -Multifocal consolidation on chest X-Ray\                                                                                    -ICU\                                                    -Patient had severe respiratory dysfunction and evolved to death in 24 days                    
  -73 years old\                                           -SpO~2~ 76%\                                                        -Positive nasopharyngeal swab test for SARS-CoV-2                                                                            -Mechanical ventilation\                                                                                                                                
  -Male\                                                   -Dyspnea\                                                                                                                                                                                        -Suspended MMF                                                                                                                                          
  -COVID-19 infection manifestation 16.4 years after LT\   -Cough\                                                                                                                                                                                                                                                                                                                                                  
  -HBV\                                                    -Malaise                                                                                                                                                                                                                                                                                                                                                 
  -MMF                                                                                                                                                                                                                                                                                                                                                                                                              

  [Case 5]{.ul}\                                           -Fever\                                                             -Positive nasopharyngeal swab test for SARS-CoV-2                                                                            -Hydroxychloroquine\                                     -Patient had a satisfactory clinical evolution, with no complications                          
  -76 years old\                                           -SpO~2~ 98%\                                                                                                                                                                                     -FK maintained                                                                                                                                          
  -Female\                                                 -Thoracic pain                                                                                                                                                                                                                                                                                                                                           
  -COVID-19 infection manifestation 26.5 years after LT\                                                                                                                                                                                                                                                                                                                                                            
  -HCV\                                                                                                                                                                                                                                                                                                                                                                                                             
  -FK                                                                                                                                                                                                                                                                                                                                                                                                               

  [Case 6]{.ul}\                                           -SpO~2~ 100%\                                                       -Positive nasopharyngeal swab test for SARS-CoV-2                                                                            -FK maintained                                           -Patient had a satisfactory clinical evolution, with no complications                          
  -46 years old\                                           -Diarrhea                                                                                                                                                                                                                                                                                                                                                
  -Female\                                                                                                                                                                                                                                                                                                                                                                                                          
  -COVID-19 infection manifestation 6.4 years after LT\                                                                                                                                                                                                                                                                                                                                                             
  -Acute liver failure\                                                                                                                                                                                                                                                                                                                                                                                             
  -FK                                                                                                                                                                                                                                                                                                                                                                                                               
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ALT, alanine aminotransferase; CT, computed tomography; CRP, C-reactive protein; FK, tacrolimus; GGT, gamma-glutamyl transpeptidase; HCC, hepatocellular carcinoma; HR, heart rate; LT, liver transplantation; Lymphs, lymphocyte; MMF, mycophenolate mofetil; MPA, methylprednisolone; RT-PCR, real-time polymerase chain reaction; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus-2; SpO~2~, peripheral capillary oxygen saturation; TBIL, total bilirubin; UCI, intensive care unit; VHB, hepatitis B virus; WBC, white blood cells.

###### COVID-19 infection in kidney transplant patients.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Article                                   Patients                                    Clinical manifestation                                                                                          Laboratory examination                                                  Treatment                                                                                                                                                        Outcome
  ----------------------------------------- ------------------------------------------- --------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------
  Bussalino et al. (22) (Case report)       -32 years old\                              -Three days of fever (38°C)\                                                                                    -CRP 47.9 mg/L\                                                         -Prednisone dose was increased to 15 mg/day\                                                                                                                     -Patient had a satisfactory clinical evolution -Renal function remained similar to that at admission
                                            -Male\                                      -SpO2 97%\                                                                                                      -PCT 0.33 μg/L\                                                         -FK+MMF maintained\                                                                                                                                              
                                            -3 years KT\                                -Dyspnea\                                                                                                       -Creatinine 2.6 mg/dl\                                                  -hydroxychloroquine\                                                                                                                                             
                                            -Deceased donor\                            -Non-productive cough                                                                                           -GFR 31 ml/min/1.73m^2^\                                                -Oseltamivir\                                                                                                                                                    
                                            -ESRD etiology was unknown\                                                                                                                                 -RT-PCR positive for SARS-CoV-2                                         -Ceftaroline\                                                                                                                                                    
                                            -FK+MMF+Prednisone                                                                                                                                                                                                                  -Oxygen administration by nasal catheters                                                                                                                        

  Marx et al. (28) (Correspondence)         -58 years old\                              -Fever (38°C)\                                                                                                  -RT-PCR positive for SARS-CoV-2\                                        -Belatacept and MMF suspended at hospital admission                                                                                                              -Patient had a satisfactory evolution, without the necessity of mechanical ventilation or supplementary oxygen\
                                            -Male\                                      -Dyspnea\                                                                                                       -Pulmonary ground-glass opacities on CT                                                                                                                                                                                                  -Introduced cyclosporine on the 7^th^ hospitalization day
                                            -3 years KT\                                -Cough\                                                                                                                                                                                                                                                                                                                                                  
                                            -Renal vein thrombosis\                     -History of contact with a person who received a COVID-19 diagnosis                                                                                                                                                                                                                                                                                      
                                            -Balatacept+MMF+Prednisone                                                                                                                                                                                                                                                                                                                                                                           

  Bartiromo et al. (23) (Case report)       -36 years old\                              -Afebrile (36.3°C)\                                                                                             -CRP 67 mg/L\                                                           -Lopinavir/ritonavir\*\                                                                                                                                          \- On the 4th hospitalization day, the patient presented with abdominal pain, nausea, and diarrhea.\
                                            -Female\                                    -SpO2 97%\                                                                                                      -Creatinine 2.29 mg/dl\                                                 -Hydroxychloroquine -Ceftriaxone\                                                                                                                                -Had a good clinical evolution\
                                            -First KT in 1993\                          -Fatigue\                                                                                                       -GFR 27 ml/min\                                                         \*On the 2^nd^ hospitalization day, patient presented with nausea and diarrhea, so the therapy with lopinavir/ritonavir was replaced with darunavir/cobicistat   -Medical release on the 9th hospitalization day
                                            -Second KT in 1995 (Cadaveric donor)\       -Dry cough\                                                                                                     -RT-PCR positive for SARS-CoV-2                                                                                                                                                                                                          
                                            -Senior-Loken syndrome\                     -Coryza\                                                                                                                                                                                                                                                                                                                                                 
                                            -FK+Corticoesteroids                        -History of contact with her mother who received a COVID-19 diagnosis                                                                                                                                                                                                                                                                                    

  Ning et al. (24) (Case report)            -29 years old\                              -Fever (37.7°C)\                                                                                                -First test RT-PCR negative for SARS-CoV-2\                             -TMP-SMX (admission)\                                                                                                                                            -On the 3^rd^ hospitalization day, patient presented with dizziness, nausea, vomit, oliguria, and hematuria\
                                            -Male\                                      -Without other symptoms in admission\                                                                           -Pulmonary ground-glass opacities on CT\                                -Immunosuppressive treatment was maintained\                                                                                                                     -Laboratory tests revealed elevated creatinine levels and hyponatremia\
                                            -2 years KT (Living donor)\                 -During hospitalization (2^nd^ day), patient presented with nasal stuffiness, hyporexia, nausea, and vomiting   -Second test RT-PCR positive for SARS-CoV-2 (3rd hospitalization day)   -Lopinavir/ritonavir (after RT-PCR test was positive)\                                                                                                           -Patient received fluids and had better renal function\
                                            -Cyclosporine+MMF+methylprednisolone                                                                                                                                                                                                -Probiotics                                                                                                                                                      -Medical release on the 12th hospitalization day

  Wang et al. (10) (Correspondence)         -49 years old\                              -Fever for six days\                                                                                            -WBC 7.18×10^9^/L,\                                                     -Nebulized α- interferon\                                                                                                                                        -Patient had a good clinical evolution, without an impact on renal function
                                            -Male\                                      -Without other symptoms in admission                                                                            -Lymphs 0.59×10^9^/L\                                                   -Immunosuppressive treatment was maintained\                                                                                                                     
                                            -2 years KT\                                                                                                                                                -CRP 22.73 mg/L\                                                        -Ribavirin\                                                                                                                                                      
                                            -Cyclosporine+MMF+ Prednisone                                                                                                                               -PCT 0.36 μg/L\                                                         -Lopinavir/ritonavir\                                                                                                                                            
                                                                                                                                                                                                        -Creatinine 1.44 mg/dl\                                                 -Methylprednisolone\                                                                                                                                             
                                                                                                                                                                                                        -RT-PCR positive for SARS-CoV-2\                                        -Oxygen administration by nasal catheters                                                                                                                        
                                                                                                                                                                                                        -Pulmonary ground-glass opacities on CT                                                                                                                                                                                                  

                                            [Case 1]{.ul}\                              -Fever (38.9°C)\                                                                                                -WBC 4.73×10^9^/L,\                                                     -Antiviral therapy (oseltamivir or arbidol)                                                                                                                      -Patient had a good clinical evolution, without the necessity of mechanical ventilation
                                            -38 years old\                              -SpO2 99%\                                                                                                      -Lymphs 0.59×10^9^/L\                                                                                                                                                                                                                    
                                            -Male\                                      -Cough                                                                                                          -CRP 6.68 mg/L\                                                                                                                                                                                                                          
                                            -3 months KT (Deceased donor)                                                                                                                               -Creatinine 1.10 mg/dl\                                                                                                                                                                                                                  
                                                                                                                                                                                                        -RT-PCR positive for SARS-CoV-2                                                                                                                                                                                                          

                                            [Case 2]{.ul}\                              -Fever (38.3°C)\                                                                                                -WBC 17.67×10^9^/L,\                                                    -Antiviral therapy (oseltamivir or arbidol)\                                                                                                                     -Patient had anuria, persistent fever, normal CT chest, and an elevation of creatinine levels\
                                            -64 years old\                              -SpO2 96%\                                                                                                      -Lymphs 0.55×10^9^/L\                                                   -Cefixime                                                                                                                                                        - Realized methylprednisolone pulse therapy, due rejection suspect\
                                            -Male\                                      -Cough\                                                                                                         -CRP 337.11 mg/L\                                                                                                                                                                                                                        -Had a good clinical evolution
                                            -4 years KT (Deceased donor)                -Sputum\                                                                                                        -Creatinine 4.65 mg/dl\                                                                                                                                                                                                                  
                                                                                        -Fatigue                                                                                                        -RT-PCR positive for SARS-CoV-2                                                                                                                                                                                                          

  Zhang et al. (25) (Case Series)           [Case 3]{.ul}\                              -Fever (39°C)\                                                                                                  -WBC 5.67×10^9^/L,\                                                     -Antiviral therapy (oseltamivir or arbidol)\                                                                                                                     -Patient had a good clinical evolution, without the necessity of mechanical ventilation
                                            -37 years old\                              -SpO2 99%\                                                                                                      -Lymphs 0.31×10^9^/L\                                                   -IV immunoglobulin                                                                                                                                               
                                            -Female\                                    -Cough                                                                                                          -CRP 9.77 mg/L\                                                                                                                                                                                                                          
                                            -5 months KT (Deceased donor)                                                                                                                               -Creatinine 1.54 mg/dl\                                                                                                                                                                                                                  
                                                                                                                                                                                                        -RT-PCR positive for SARS-CoV-2                                                                                                                                                                                                          

  [Case 4]{.ul}\                            -Fever (39.8°C)\                            -WBC 3.99×10^9^/L,\                                                                                             -Antiviral therapy (oseltamivir or arbidol)                             -Patient had a good clinical evolution, without the necessity of mechanical ventilation                                                                          
  -47 years old\                            -SpO2 98%\                                  -Lymphs 0.51×10^9^/L\                                                                                                                                                                                                                                                                                                                                    
  -Male\                                    -Cough\                                     -CRP 13.38 mg/L\                                                                                                                                                                                                                                                                                                                                         
  -11 months KT (Deceased donor)            -Sputum\                                    -Creatinine 1.66 mg/dl\                                                                                                                                                                                                                                                                                                                                  
                                            -Fatigue                                    -RT-PCR positive for SARS-CoV-2                                                                                                                                                                                                                                                                                                                          

  [Case 5]{.ul}\                            -Fever (39.1°C)\                            -WBC 6.44×10^9^/L,\                                                                                             -Antiviral therapy (oseltamivir or arbidol)                             -Patient had a good clinical evolution, without the necessity of mechanical ventilation                                                                          
  -38 years old\                            -SpO2 97%\                                  -Lymphs 0.91×10^9^/L\                                                                                                                                                                                                                                                                                                                                    
  -Male\                                    -Cough\                                     -CRP 33.72 mg/L\                                                                                                                                                                                                                                                                                                                                         
  -3 years KT (Deceased donor)              -Sputum\                                    -Creatinine 1.53 mg/dl\                                                                                                                                                                                                                                                                                                                                  
                                            -Fatigue                                    -RT-PCR positive for SARS-CoV-2                                                                                                                                                                                                                                                                                                                          

  Chen et al. (26) (Case report)            -49 years old\                              -Fever (38.6°C)\                                                                                                -WBC 3.44×10^9^/L,\                                                     -MMF and prednisolone were suspended\                                                                                                                            -Patient had worsening blood oxygen saturation, and oxygen inhalation was initiated.\
                                            -Male\                                      -Hyporexia\                                                                                                     -Lymphs 0.43×10^9^/L\                                                   -Methylprednisolone\                                                                                                                                             -Had a satisfactory clinical evaluation
                                            -6 years KT (Deceased donor)\               -Dry cough                                                                                                      -CRP 74.34 mg/L\                                                        -Ribavirin\                                                                                                                                                      
                                            -FK+MMF\                                                                                                                                                    -Creatinine 1.84 mg/dl\                                                 -Immunoglobin\                                                                                                                                                   
                                            -Prednisolone                                                                                                                                               -RT-PCR positive for SARS-CoV-2\                                        -Moxifloxacin                                                                                                                                                    
                                                                                                                                                                                                        -Pulmonary ground-glass opacities on CT                                                                                                                                                                                                  

  Seminari et al. (27) (Case report)        -50 years old\                              -Fever (37.3°C)\                                                                                                -WBC 3.2×10^9^/μL\                                                      -Immunosuppressive treatment was maintained\                                                                                                                     -Patient had a good clinical evolution, without the necessity of mechanical ventilation
                                            -Male\                                      -Cough                                                                                                          -Lymphs 0.6×10^9^/μL\                                                   -Lopinavir/ritonavir\                                                                                                                                            
                                            -First KT 1993, failure 2008\                                                                                                                               -RT-PCR positive SARS-CoV-2\                                            -Ceftriaxone                                                                                                                                                     
                                            -Second KT 2016 (4 years)\                                                                                                                                  -Chest x-ray showed interstitial lesions                                                                                                                                                                                                 
                                            -IgA nephropathy\                                                                                                                                                                                                                                                                                                                                                                                    
                                            -FK+MMF                                                                                                                                                                                                                                                                                                                                                                                              

  Gandolfini et al. (29) (Correspondence)   [Case 1]{.ul}\                              -Fever (38-39°C)\                                                                                               -WBC 6.56×10^9^/L,\                                                     -FK+MMF was discontinued\                                                                                                                                        -Patients presented with significant worsening of respiratory function and evolved to death
                                            -75 years old\                              -Cough\                                                                                                         -Lymphs 0.80×10^9^/L\                                                   -Lopinavir/ritonavir\                                                                                                                                            
                                            -Male\                                      -Myalgia\                                                                                                       -CRP 180 mg/L\                                                          -Hydroxychloroquine                                                                                                                                              
                                            -10 years KT (Deceased donor)\              -Dyspnea                                                                                                        -PCT 1.29 ng/ml\                                                                                                                                                                                                                         
                                            -FK+MMF\                                                                                                                                                    -Creatinine 2.2 mg/dl\                                                                                                                                                                                                                   
                                            -Prednisolone                                                                                                                                               -RT-PCR positive for SARS-CoV-2\                                                                                                                                                                                                         
                                                                                                                                                                                                        -Pulmonary ground-glass opacities on CT                                                                                                                                                                                                  

  [Case 2]{.ul}\                            -Fever (38-39°C)\                           -WBC 2.54×10^9^/L,\                                                                                             -FK+MMF was discontinued\                                               -Patient received non-invasive oxygen therapy\                                                                                                                   
  -52 years old\                            -Cough\                                     -Lymphs 0.11×10^9^/L\                                                                                           -Dorunavir/cobicistat\                                                  -Had a good clinical evaluation                                                                                                                                  
  -Female\                                  -Fatigue\                                   -CRP 158 mg/L\                                                                                                  -Hydroxychloroquine                                                                                                                                                                                                                      
  -8 months KT (Deceased donor)\            -Dyspnea\                                   -PCT 0.98 ng/ml\                                                                                                                                                                                                                                                                                                                                         
  -FK+MMF\                                  -Diarrhea                                   -Creatinine 2.4 mg/dL\                                                                                                                                                                                                                                                                                                                                   
  -Prednisolone                                                                         -RT-PCR positive for SARS-CoV-2\                                                                                                                                                                                                                                                                                                                         
                                                                                        -Pulmonary ground-glass opacities on CT                                                                                                                                                                                                                                                                                                                  

  Guillen et al. (30) (Case report)         -50 years old\                              \*1^st^ day\                                                                                                    \*1^st^ day\                                                            -FK+Everolimus was discontinued\                                                                                                                                 -Patient had worsening respiratory function, and mechanical ventilation was initiated.\
                                            -Male\                                      -Fever (38.2°C)\                                                                                                -WBC 8.58×10^9^/L\                                                      -Lopinavir/ritonavir\                                                                                                                                            -Until the publication of this article, the patient remains in intensive respiratory support
                                            -3^rd^ KT (4 years ago)\                    -Vomiting\                                                                                                      -CRP\<0.50 mg/dL\                                                       -Hydroxychloroquine\                                                                                                                                             
                                            -IgA nephropathy\                           -Signs of dehydration \*5^th^ day\                                                                              -Creatinine 1.6 mg/dL,\                                                 -Ceftaroline+meropenem                                                                                                                                           
                                            -FK+everolimus+ prednisone                  -Fever (37.4°C)\                                                                                                -GFR 50 mL/min \*5^th^ day\                                                                                                                                                                                                              
                                                                                        -Crackles in the right lower lung\                                                                              -WBC 10.15×10^9^/L\                                                                                                                                                                                                                      
                                                                                        -Conjunctivitis of the left eye                                                                                 -CRP 13.2 mg/dL\                                                                                                                                                                                                                         
                                                                                                                                                                                                        -Creatinine 1.6 mg/dL,\                                                                                                                                                                                                                  
                                                                                                                                                                                                        -GFR 50 mL/min\                                                                                                                                                                                                                          
                                                                                                                                                                                                        -RT-PCR positive for SARS-CoV-2                                                                                                                                                                                                          

  Fernández-Ruiz et al. (7) (Case series)   [Case 1]{.ul}\                              -Fever\                                                                                                         -Unilateral consolidation on chest X-ray\                               -Lopiravir/ritonavir\                                                                                                                                            -Patient had respiratory failure and atrial fibrillation\
                                            -78 years old\                              -SpO~2~ 89%\                                                                                                    -RT-PCR positive for SARS-CoV-2                                         -Reduction of FK doses                                                                                                                                           -Evolved to death after 5 days
                                            -Male\                                      -Dyspnea                                                                                                                                                                                                                                                                                                                                                 
                                            -8.3 years of KT\                                                                                                                                                                                                                                                                                                                                                                                    
                                            -Polycystic kidney disease -Prednisone+FK                                                                                                                                                                                                                                                                                                                                                            

  [Case 2]{.ul}\                            -Fever\                                     -Unilateral consolidation on chest X-ray\                                                                       -Lopinavir/ritonavir\                                                   -Patient had myopericarditis\                                                                                                                                    
  -73 years old\                            -SpO~2~ 94%\                                -RT-PCR positive for SARS-CoV-2                                                                                 -Reduction of FK doses\                                                 -Had a satisfactory clinical evolution                                                                                                                           
  -Male\                                    -Dyspnea\                                                                                                                                                   -Suspended prednisone+MPA                                                                                                                                                                                                                
  -1.8 years of KT\                         -Cough                                                                                                                                                                                                                                                                                                                                                                                               
  -Hypertensive nephropathy\                                                                                                                                                                                                                                                                                                                                                                                                                     
  -Prednisone+FK+MPA                                                                                                                                                                                                                                                                                                                                                                                                                             

  [Case 3]{.ul}\                            -SpO~2~ 90%\                                -RT-PCR positive for SARS-CoV-2                                                                                 -Lopinavir/ritonavir\                                                   -Patient had worsening respiratory function\                                                                                                                     
  -80 years old\                            -Dyspnea\                                                                                                                                                   -Hydroxychloroquine\                                                    -Evolved to death after 16 days                                                                                                                                  
  -Male\                                    -Cough\                                                                                                                                                     -Reduction of FK doses\                                                                                                                                                                                                                  
  -3.8 years of KT\                         -Hyporexia\                                                                                                                                                 -Suspended MPA                                                                                                                                                                                                                           
  -Hypertensive nephropathy\                -Myalgia                                                                                                                                                                                                                                                                                                                                                                                             
  -Prednisone+FK+MPA                                                                                                                                                                                                                                                                                                                                                                                                                             

  [Case 4]{.ul}\                            -Fever\                                     -Bilateral interstitial pneumonia\                                                                              -Lopinavir/ritonavir\                                                   -Patient evolved to death after 16 days                                                                                                                          
  -71 years old\                            -SpO~2~ 97%\                                -RT-PCR positive for SARS-CoV-2                                                                                 -Hydroxychloroquine\                                                                                                                                                                                                                     
  -Female\                                  -Dyspnea\                                                                                                                                                   -Suspended MPA+prednisone                                                                                                                                                                                                                
  -6 years of KT\                           -Cough\                                                                                                                                                                                                                                                                                                                                                                                              
  -Unknown cause of renal failure\          -Sore throat                                                                                                                                                                                                                                                                                                                                                                                         
  -Prednisone+FK+MPA                                                                                                                                                                                                                                                                                                                                                                                                                             

  [Case 5]{.ul}\                            -Fever\                                     -RT-PCR positive for SARS-CoV-2                                                                                 -Hydroxychloroquine\                                                    -Patient showed an improvement in abdominal pain and was discharged home but returned to the hospital due to clinical worsening                                  
  -71 years old\                            -SpO~2~ 100%\                                                                                                                                               -Intravenous immunoglobulin\                                                                                                                                                                                                             
  -Male\                                    -Epigastric pain                                                                                                                                            -Reduction of FK doses                                                                                                                                                                                                                   
  -30.1 years of KT\                                                                                                                                                                                                                                                                                                                                                                                                                             
  -Polycystic kidney disease\                                                                                                                                                                                                                                                                                                                                                                                                                    
  -FK                                                                                                                                                                                                                                                                                                                                                                                                                                            

  [Case 6]{.ul}\                            -Fever\                                     -Bilateral interstitial pneumonia\                                                                              -Hydroxychloroquine\                                                    -Patient had a good clinical evolution, without the necessity of mechanical ventilation                                                                          
  -76 years old\                            -SpO~2~ 96%\                                -RT-PCR positive for SARS- CoV-2                                                                                -Suspended MMF                                                                                                                                                                                                                           
  -Male\                                    -Rhinorrhea                                                                                                                                                                                                                                                                                                                                                                                          
  -14.8 years of KT\                                                                                                                                                                                                                                                                                                                                                                                                                             
  -IgA nephropathy\                                                                                                                                                                                                                                                                                                                                                                                                                              
  -Prednisone+MMF+rapamycin                                                                                                                                                                                                                                                                                                                                                                                                                      

  [Case 7]{.ul}\                            -Fever\                                     -RT-PCR positive for SARS- CoV-2                                                                                -Hydroxychloroquine\                                                    Patient had worsening respiratory function but showed mild radiological improvement                                                                              
  -39 years old\                            -SpO~2~ 100%\                                                                                                                                               -Suspended FK+everolimus                                                                                                                                                                                                                 
  -Male\                                    -Myalgia                                                                                                                                                                                                                                                                                                                                                                                             
  -16.8 years of KT\                                                                                                                                                                                                                                                                                                                                                                                                                             
  -Polycystic kidney disease\                                                                                                                                                                                                                                                                                                                                                                                                                    
  -Prednisone+FK+ Everolimus                                                                                                                                                                                                                                                                                                                                                                                                                     

  [Case 8]{.ul}\                            -Fever\                                     -Unilateral focal consolidation on chest X-ray\                                                                 -Lopinavir/ritonavir\                                                   -Patient had a positive clinical evolution                                                                                                                       
  -65 years old\                            -SpO~2~ 93%\                                -RT-PCR positive for SARS- CoV-2                                                                                -Hydroxychloroquine\                                                                                                                                                                                                                     
  -Male\                                    -Myalgia\                                                                                                                                                   -Reduced doses of MPA and FK                                                                                                                                                                                                             
  -6.5 years of KT\                         -Dyspnea\                                                                                                                                                                                                                                                                                                                                                                                            
  -Chronic interstitial nephritis\          -Cough                                                                                                                                                                                                                                                                                                                                                                                               
  - Prednisone+FK+MPA                                                                                                                                                                                                                                                                                                                                                                                                                            
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Note:** CRP, C-reactive protein; CT, computed tomography; ESRD, end-stage renal disease; FK, tacrolimus; AZA, azathioprine; KT; kidney transplantation; Lymphs, lymphocyte; MMF, mycophenolate mofetil; PCT, procalcitonin; RT-PCR, real-time polymerase chain reaction; SpO~2~, peripheral capillary oxygen saturation; UCI, intensive care unit; WBC, white blood cells.

###### COVID-19 infection in SOT, LT, and KT patients. Overall parameters and prevalence/fatality rate in COVID-19 in SOT, liver and kidney patients.

                                              OVERALL PARAMETERS                                     
  ------------------------------------------- -------------------- ---------------- ---------------- -------
  Cases (N)                                   16                   23               39               \-
  Age (years)                                 55.25 (±23.8)        54.65 (±16.42)   54.65 (±16.42)   0.603
                                              61 (0.5-79)          50 (29-80)       52 (0.5-80)      
  Time after transplant to COVID-19 (years)   8.40 (±8.50)         6.79 (±7.84)     7.28 (±7.95)     0.686
                                              5.95 (0.01-26.5)     4 (0.25-30.1)    4 (0.01-30.10)   
  Death (N)                                   6                    4                10               0.157
  Fatality rate (%) (death/total)             37.5%                17.39%           25.64%           0.157
  Fatality rate ≥60 years old (%)             62.5%                44.44%           52.94%           0.457

                           PREVALENCE AND FATALITY RATE (%) (≥60 years old vs \<60 years old)                 
  ------------------------ -------------------------------------------------------------------- ------------- -----------
  Liver transplant                                                                                            
   Prevalence rate (%)     8 (50%)                                                              8 (50%)       0.501
   Fatality rate (%)       62.5%                                                                12.5%         **0.006**
  Kidney transplant                                                                                           
   Prevalence rate (%)     9 (39.13%)                                                           14 (60.87%)   0.501
   Fatality rate (%)       44.44%                                                               0%            **0.039**
  Solid organ transplant                                                                                      
   Prevalence rate (%)     17 (43.58%)                                                          22 (56.42%)   0.501
   Fatality rate (%)       52.94%                                                               4.54%         **0.001**

**Note:** Number and percentage; mean and standard deviation; median and range.
